Vivanza Biosciences' Auditors Issue Unmodified Opinion on Financial Results for Year Ended March 31, 2026
Vivanza Biosciences Limited has received an audit report regarding its financial performance up to March 31, 2026. The company’s Statutory Auditors, M/S. Shivam Soni & Co of Ahmedabad, issued the report confirming the Audited Financial Results for the quarter and year ending March 31, 2026.The auditors provided an unmodified opinion on the financial results of Vivanza Biosciences Limited as of the end of the fiscal year. This concludes the review process for the company's annual accounts up to that period.
Stock Price Movement
As of 10:14, Vivanza Biosciences Ltd is ticking slightly lower at ₹1.87, with shares falling by 0.53%. The stock is currently trading completely flat, as the intraday high and low are identical at ₹1.87.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.